Nutrition Guidance for Patients on Hormone Therapy
Did you know that what you eat, how much you move, and other health practices can not only affect your fight against prostate cancer….but also lower your risk of heart...Read More
Prostate Cancer Disparities and the “Last Mile” Problem
Black men are at higher risk of being diagnosed with prostate cancer vs. white men, and, once diagnosed, in the U.S. they are more than twice as likely to die...Read More
Beyond the Prostate: Don’t Forget About the Rest of Your Body!
Treatment of prostate cancer at any stage can be all-consuming. But don’t forget about the rest of your body! This means you still need to think about screening for other...Read More
Breaking News: FDA Approves Talazoparib + Enzalutamide for Metastatic Castration-Resistant Prostate Cancer
The FDA has approved a new medication, talazoparib, in combination with enzalutamide for patients with metastatic castration-resistant prostate cancer (mCRPC) who also have mutations in certain genes involved in DNA repair....Read More
PSMA PET Imaging
PSMA PET is a newer, highly sensitive imaging scan that can detect prostate cancer metastases much earlier, when they are much smaller. It is approved for two types of patients:...Read More
Liquid Biopsy: Catching Cancer Cells in the Blood
Snapshot of Cancer Metastatic prostate cancer looks a lot different from cancer that is confined to the prostate. That’s because over time, as it develops the ability to spread beyond...Read More
More benefits of a plant-based diet: Better sexual and urinary function
After a prostate cancer diagnosis, patients often wonder what they can do to reduce the chance of their cancer worsening or recurring, to improve their recovery after treatment, or simply...Read More
Colorful Summer Potluck Salad
PCF’s Home Run Challenge wraps on Father’s Day, which brings us to our final installment of Game Day recipes! Whether you’re celebrating with a family BBQ or having friends over...Read More
Breaking News: FDA Approves Combination of Olaparib + Abiraterone for Metastatic Castration-Resistant Prostate Cancer in Patients with BRCA Gene Mutations
The U.S. FDA has approved olaparib in combination with abiraterone (plus prednisone or prednisolone) for patients with metastatic castration-resistant prostate cancer (mCRPC) who also have a mutation in specific genes...Read More
Prostate Cancer Survivorship, Part 1
Survivor. What does that word bring to mind? (Besides, of course, the name of the rock band whose song, “Eye of the Tiger,” went double-platinum in 1982 and was...Read More